ES2032447T3 - Nuevos anticuerpos monoclonales y su produccion y uso. - Google Patents

Nuevos anticuerpos monoclonales y su produccion y uso.

Info

Publication number
ES2032447T3
ES2032447T3 ES198787306664T ES87306664T ES2032447T3 ES 2032447 T3 ES2032447 T3 ES 2032447T3 ES 198787306664 T ES198787306664 T ES 198787306664T ES 87306664 T ES87306664 T ES 87306664T ES 2032447 T3 ES2032447 T3 ES 2032447T3
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
production
new monoclonal
streptococci
immunoglobulins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787306664T
Other languages
English (en)
Spanish (es)
Inventor
Graham Arthur William Rook
Jennifer Jane Edge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of ES2032447T3 publication Critical patent/ES2032447T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES198787306664T 1986-07-29 1987-07-28 Nuevos anticuerpos monoclonales y su produccion y uso. Expired - Lifetime ES2032447T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868618443A GB8618443D0 (en) 1986-07-29 1986-07-29 Monoclonal antibodies

Publications (1)

Publication Number Publication Date
ES2032447T3 true ES2032447T3 (es) 1993-02-16

Family

ID=10601843

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787306664T Expired - Lifetime ES2032447T3 (es) 1986-07-29 1987-07-28 Nuevos anticuerpos monoclonales y su produccion y uso.

Country Status (13)

Country Link
US (1) US6391634B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0255342B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS63119498A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE76512T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU601455B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3779207D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK392387A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2032447T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB8618443D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3005450T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE59984B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ221230A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA875551B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US5271927A (en) * 1986-02-13 1993-12-21 Celltech Limited Antibody conjugates with macrocyclic ligands
CA1303983C (en) * 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
ATE195022T1 (de) 1987-04-27 2000-08-15 Unilever Nv Spezifische bindungstestverfahren
US4855240A (en) * 1987-05-13 1989-08-08 Becton Dickinson And Company Solid phase assay employing capillary flow
GB8719042D0 (en) 1987-08-12 1987-09-16 Parker D Conjugate compounds
GB8719041D0 (en) * 1987-08-12 1987-09-16 Parker D Conjugate compounds
GB8726271D0 (en) * 1987-11-10 1987-12-16 Univ London Protein glycosylation assay
US5342936A (en) * 1989-02-10 1994-08-30 David Parker Tetra-aza macrocycles and processes for their preparation
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
US5247077A (en) * 1989-06-23 1993-09-21 Celltech Limited Tri-aza macrocycles and processes for their preparation
JPH0726963B2 (ja) * 1989-12-28 1995-03-29 丸善石油化学株式会社 悪性腫瘍に対する抗体、及びこの抗体を用いた悪性腫瘍の判別方法
WO2000061636A2 (en) * 1999-04-14 2000-10-19 Research Corporation Technologies, Inc. Aberrantly glycosylated antibodies as marker for cancer
GB0002660D0 (en) * 2000-02-04 2000-03-29 Biomade B V Method of stabilizing a hydrophobin-containing solution and a method of coatinga surface with a hydrophobin
IL154853A0 (en) * 2000-10-27 2003-10-31 Chiron Spa Nucleic acids and proteins from streptococcus groups a & b
FI20011671A7 (fi) 2001-08-20 2003-02-21 Carbion Oy Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
EP2322209A3 (en) * 2002-08-20 2012-02-01 Glykos Finland Oy Tumor specific oligosaccharide epitopes and use thereof
CA3215117A1 (en) 2021-04-01 2022-10-06 Becton, Dickinson And Company Methods for enhancing specificity and sensitivity of group a streptococcus immunoassay

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790447A (en) * 1972-07-05 1974-02-05 Abbott Lab Streptococci diagnostic method
SE7712244L (sv) * 1977-10-31 1979-05-01 Jonsson U R S Forfarande for framstellning av preparationer av avdodade bakterier
US4292296A (en) 1978-09-12 1981-09-29 Baxter Travenol Laboratories, Inc. Diagnostic method
GB2093993A (en) 1980-07-25 1982-09-08 Otsuka Pharma Co Ltd Method for determining tumor-associated glucose side chain method for diagnosing tumors and kit for diagnosing tumors
US4489167A (en) * 1981-06-02 1984-12-18 Baxter Travenol Laboratories, Inc. Methods and compositions for cancer detection
EP0114818B1 (en) * 1982-08-09 1987-08-12 Centocor, Inc. Immunoassay for carbohydrate antigenic determinant
EP0141818A1 (en) * 1983-04-18 1985-05-22 Quidel Removal of self-binding and staph a cross-reactivity of anti-strep antibody
JPS608228A (ja) * 1983-06-28 1985-01-17 Kyowa Hakko Kogyo Co Ltd モノクロ−ナル抗体
CA1231050A (en) * 1984-01-27 1988-01-05 Joseph W. Holland PROCEDURE FOR DETECTING .beta.-HEMOLYTIC STREPTOCOCCUS ANTIGENS
US4618576A (en) * 1984-02-27 1986-10-21 Becton Dickinson And Company Diagnostic test for Streptococcus A
US4659659A (en) * 1985-01-22 1987-04-21 Monsanto Company Diagnostic method for diseases having an arthritic component

Also Published As

Publication number Publication date
JPS63119498A (ja) 1988-05-24
GB8618443D0 (en) 1986-09-03
AU601455B2 (en) 1990-09-13
DK392387D0 (da) 1987-07-28
GB2195343B (en) 1990-08-01
GR3005450T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-05-24
NZ221230A (en) 1990-04-26
DE3779207D1 (de) 1992-06-25
ATE76512T1 (de) 1992-06-15
US6391634B1 (en) 2002-05-21
IE872041L (en) 1988-01-29
GB8717792D0 (en) 1987-09-03
AU7626787A (en) 1988-02-04
ZA875551B (en) 1988-04-27
IE59984B1 (en) 1994-05-04
GB2195343A (en) 1988-04-07
EP0255342A1 (en) 1988-02-03
EP0255342B1 (en) 1992-05-20
DK392387A (da) 1988-02-12

Similar Documents

Publication Publication Date Title
ES2032447T3 (es) Nuevos anticuerpos monoclonales y su produccion y uso.
ES2124209T3 (es) Anticuerpos monoclonales mejorados reactivos con caquectina.
FI893300A7 (fi) Ihmisen B-solun pinta-antigeenille spesifinen kimeerinen vasta-aine
DE3852054D1 (de) Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung.
AR243931A1 (es) Antigeno purificado,conjunto de reactivos para la deteccion de anticuerpos anti-hiv-2 en un fluido biologico que comprende dichos antigenos,anticuerpos,hibridomas y procedimientos.
BE863810A (fr) Procede de preparation d'un antigene et d'un anticorps
FR2545100B1 (fr) Procede d'obtention de cultures d'hepatocytes humains, les cultures obtenues et leurs applications biologiques et biochimiques
ATE93629T1 (de) Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren.
ATE125870T1 (de) Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung.
DE3278505D1 (en) Hybridoma antibody which inhibits interleukin-2 activity and its use as a reagent for interleukin-2 detection, the production of said antibody, a process for producing hybrid anti-interleukin-2 antibody producing cells, and such cells
PT86117A (fr) Anticorps monoclonaux antigram (-), procede de preparation et applications
FI902735A7 (fi) Monoklonaalinen vasta-aine, joka reagoi tiettyyn laajasti erilaisissa ihmisleukemia- ja lymfomasoluissa esiintyvään antigeeniin ja menetelmä sen käyttämiseksi diagnoosiin ja hoitoon
ATE87941T1 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
LTIP1517A (en) Nucleic acids, proteins, organisms, cells, monoclonal antibody, methods of identification and diagnosis, analytical and model systems, pharmaceutical compositions
JPS6461499A (en) Monoclonal antibody to human papilloma viruses 16 type e7 protein, and production and use thereof
NO870174D0 (no) Modifisert b2-mikroglobulin.
AU6873587A (en) Monoclonal antibodies useful in the identification of microorganisms causing peridontal disease
FI873606A7 (fi) Ihmisen glykoalbumiinin määrittämiseen käyttökelpoisia vasta-aineita.
BE888855A (fr) Procede d'obtention de preparations de toxoplasmes pour le diagnostic de la toxoplasmose, et preparations ainsi obtenues
IT1239065B (it) Anticorpo monoclonale che inibisce l'azione biologica del fattore piastrinico 4
AU1190388A (en) Methods and materials for hiv detection and therapy
DE68916609D1 (de) Kulturflüssigkeitskonzentrator.
PT83787A (en) Improved process for the laboratory diagnosis of infections caused by htlv 222 virus in particular
BE858407A (fr) Procede de dosage d'antigene et d'anticorps
FI870500A7 (fi) Reagenssi virus-antigeenin vasta-aineen määrittämiseksi.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 255342

Country of ref document: ES